Back
Blackbaud, Inc. Vs. Cidara Therapeutics, Inc. Industry Stock Comparison
Buy
63
BLKB
Blackbaud, Inc.
Last Price:
$62.91
Seasonality Move:
-0.68%
Buy
77
CDTX
Cidara Therapeutics, Inc.
Last Price:
$220.65
Seasonality Move:
9.28%
Buy
63
Blackbaud, Inc. (BLKB)
is a Buy
Is Blackbaud, Inc. a Buy, Sell or Hold?
-
The current Blackbaud, Inc. [BLKB] share price is $62.90. The Score for BLKB is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
BLKB is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
77
Cidara Therapeutics, Inc. (CDTX)
is a Buy
Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Cidara Therapeutics, Inc. [CDTX] share price is $220.65. The Score for CDTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BLKB Stock Price Chart
What is Blackbaud, Inc.'s stock price today?
-
The Blackbaud, Inc. share price today is $62.90Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BLKB is experiencing slight buying pressure.
CDTX Stock Price Chart
What is Cidara Therapeutics, Inc.'s stock price today?
-
The Cidara Therapeutics, Inc. share price today is $220.65Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
BLKB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.5 | Buy |
| Relative Strength Index (14 RSI): | 58.15 | Buy |
| Chaikin Money Flow: | 99768 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.76 - 61.82) | Buy |
| Bollinger Bands (100): | (60.09 - 66.97) | Sell |
CDTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 21.57 | Buy |
| Relative Strength Index (14 RSI): | 86.06 | Buy |
| Chaikin Money Flow: | 367727 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (151.4 - 242.46) | Buy |
| Bollinger Bands (100): | (51.44 - 167.06) | Buy |
BLKB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 62.3 | Buy |
| 20-day SMA: | 59.37 | Buy |
| 50-day SMA: | 61.39 | Buy |
| 200-day SMA: | 63.37 | Sell |
| 8-day EMA: | 61.74 | Buy |
| 20-day EMA: | 60.67 | Buy |
| 50-day EMA: | 61.37 | Buy |
| 200-day EMA: | 65.06 | Sell |
CDTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 220.33 | Buy |
| 20-day SMA: | 219.69 | Buy |
| 50-day SMA: | 150.04 | Buy |
| 200-day SMA: | 68.84 | Buy |
| 8-day EMA: | 219.45 | Buy |
| 20-day EMA: | 204.15 | Buy |
| 50-day EMA: | 162.92 | Buy |
| 200-day EMA: | 88.08 | Buy |
Blackbaud, Inc. Earnings Growth & BLKB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.35 per share, and an increase next year of $0.52 per share.
Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.
Blackbaud, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cidara Therapeutics, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||